Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schomaker

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
American Journal of Epidemiology|February 12, 2021
The Impact of Same-Day Antiretroviral Therapy Initiation Under the World Health Organization Treat-All PolicyBernhard Kerschberger, Andrew Boulle, Rudo Kuwengwa, et al.
Statistics in Medicine|April 25, 2018
Targeted maximum likelihood estimation for a binary treatment: A tutorialMiguel Angel Luque-Fernandez, Michael Schomaker, Bernard Rachet, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|January 10, 2024
Implementation of a comprehensive clinical risk management system in a university hospitalWolfgang Buchberger, Marten Schmied, Michael Schomaker, et al.
AIDS Research and Human Retroviruses|September 16, 2020
HIV-1 Subtype C Tier 3 Viruses Have Increased Infectivity Compared to Tier 2 VirusesThandeka Moyo, Fatuma H Guleid, Michael Schomaker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2020
Increased Mortality With Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South AfricaHelen Bell Gorrod, Richard Court, Michael Schomaker, et al.
AIDS Research and Therapy|October 9, 2015
Independent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort studyDominique J Pepper, Michael Schomaker, Robert J Wilkinson, et al.
Epidemiology (Cambridge, Mass.)|July 28, 2015
Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple OverimputationMichael Schomaker, Sara Hogger, Leigh F Johnson, et al.
Epidemiology (Cambridge, Mass.)|August 26, 2025
Is Checking for Sequential Positivity Violations Getting You Down? Try sPoRT!Arthur Chatton, Michael Schomaker, Miquel-Angel Luque-Fernandez, et al.
Journal of Causal Inference|April 25, 2015
Targeted Maximum Likelihood Estimation for Dynamic and Static Longitudinal Marginal Structural Working ModelsMaya Petersen, Joshua Schwab, Susan Gruber, et al.
Journal of Virology|February 13, 2015
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and PotencyRajesh Abraham Jacob, Thandeka Moyo, Michael Schomaker, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
American Journal of Epidemiology|February 12, 2021
The Impact of Same-Day Antiretroviral Therapy Initiation Under the World Health Organization Treat-All PolicyBernhard Kerschberger, Andrew Boulle, Rudo Kuwengwa, et al.
Statistics in Medicine|April 25, 2018
Targeted maximum likelihood estimation for a binary treatment: A tutorialMiguel Angel Luque-Fernandez, Michael Schomaker, Bernard Rachet, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|January 10, 2024
Implementation of a comprehensive clinical risk management system in a university hospitalWolfgang Buchberger, Marten Schmied, Michael Schomaker, et al.
AIDS Research and Human Retroviruses|September 16, 2020
HIV-1 Subtype C Tier 3 Viruses Have Increased Infectivity Compared to Tier 2 VirusesThandeka Moyo, Fatuma H Guleid, Michael Schomaker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2020
Increased Mortality With Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South AfricaHelen Bell Gorrod, Richard Court, Michael Schomaker, et al.
AIDS Research and Therapy|October 9, 2015
Independent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort studyDominique J Pepper, Michael Schomaker, Robert J Wilkinson, et al.
Epidemiology (Cambridge, Mass.)|July 28, 2015
Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple OverimputationMichael Schomaker, Sara Hogger, Leigh F Johnson, et al.
Epidemiology (Cambridge, Mass.)|August 26, 2025
Is Checking for Sequential Positivity Violations Getting You Down? Try sPoRT!Arthur Chatton, Michael Schomaker, Miquel-Angel Luque-Fernandez, et al.
Journal of Causal Inference|April 25, 2015
Targeted Maximum Likelihood Estimation for Dynamic and Static Longitudinal Marginal Structural Working ModelsMaya Petersen, Joshua Schwab, Susan Gruber, et al.
Journal of Virology|February 13, 2015
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and PotencyRajesh Abraham Jacob, Thandeka Moyo, Michael Schomaker, et al.
Pageof 8